squamous cell carcinoma of the head and neck C00 C01 C02 C03 C04 C05 C06 C09 C10 C11 C12 C13 C14
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Newly diagnosed locally advanced therapy-naïve T2 tumor or larger; or therapy-naïve tumor with positive N-stage, regardless of size • patient at age = 18 years • Adequate knowledge of the German language in spoken and written form • Patient is willing and able to attend the examinations or aftercare appointments • Exclusion of pregnancy • Written consent
Exclusion criteria
Exclusion criteria: • prior malignant tumor disease of the ENT area (except tumors of the skin and thyroid gland) within the last 5 years • Contraindication against MRI examination • Contraindication against MRI contrast agent • Severe renal failure (GFR 1.75 mg/dl) • Mental illness that restricts the understanding of the study • Pregnancy • Breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change of the therapeutic managment by an additional 18F-FDG PET/MRI examination compared to the established diagnostic algorithm | — |
Secondary
| Measure | Time frame |
|---|---|
| sensitivity/specificity comparison of the established diagnostic algorithm and PET/MRI for TNM staging | — |
Countries
Germany
Contacts
Universitätsklinikum Essen, Institut für Diagnostische und Interventionelle Radiologie und Neuroradiologie